QA: Aravive Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001513818_2023_Aravive_Inc.pdf

Logs

Graph

Absolute values for 0001513818, Aravive Inc.

  xvar xval
0 AssetsCurrent 57,970,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 270,000
3 remainder_Assets 3,913,000
4 LiabilitiesCurrent 22,112,000
5 LiabilitiesNoncurrent 2,503,000
6 remainder_Liabilities 26,881,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,036,000
9 ResearchAndDevelopmentExpense 66,938,000
10 remainder_Expenses 8,981,000
11 remainder_Revenues 9,137,000
12 remainder_NetIncome 3,496,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 62,153,000
1 Liabilities 51,496,000
2 Expenses 88,955,000
3 Revenues 9,137,000
4 StockholdersEquity 10,657,000
5 NetIncome -76,322,000
6 ComprehensiveNetIncome -76,322,000
7 BaseVar 107,618,500
8 EconomicCapitalRatio -1.02

Edgar->Model Mapping

Feature Distribution

Change over Time